Week beginning 19th February 2024
News, advocacy and media
UK Channel 4 News M.E.: Lives devastated - and sufferers told it's made up
An honest and heartbreaking report about the situation for very severe ME patients in the UK. Clare Norton tells the story of her daughter Merryn Croft and Sean O'Neill tells the story about his daughter Maeve. Both were completely let down by the health care system and died of ME. Sonya Chowdhury, CEO at Action from ME says there are still many doctors who disbelieve ME and who don't follow the clinical guideline.
News segment l
Thread
Australia Government response to recommendations of Long COVID Parliamentary Enquiry
The govt response is subtitled "Sick and tired: Casting a long shadow". Statement also made by the Minister for Health and Aged Care.
Govt Response |
Minister's Statement |
ABC News Item |
Thread
UK APPG The annual general meeting of the All Party Parliamentary Group on ME/CFS was held this week. Carol Monaghan MP has done a 2 minute video report, leading with their agreement to sign in support of the Science for ME letter to Cochrane requesting withdrawal of the Exercise therapy for CFS review. Also discussed the contribution of the 2022 APPG report to the government's implementation planning for ME/CFS. For the coming year they expect to focus on severe ME and on following progress in research including DecodeME.
Thread with link to video
Sweden The private Bragée ME clinic recently closed down suddenly. Their 2500 patients are currently not getting specialised care nor renewed prescriptions for off-label treatment from the clinic while a new offer is under the development for post viral illness within public health care. Sveriges Radio has had two news segments on this situation. Patient advocate MittEremitage asks why the off-label treatments weren't instead prescribed within clinical trials.
News segment 1 l
News segment 2 l
MittEremitage article l
Thread
ScienceAlert The Number of People With Persistent Fatigue Could Soon Double. Here's Why.
"A study from a team in Germany, published in
Internal Medicine, says that the long-lasting effects of COVID-19 on many individuals will mean they could meet the diagnostic criteria for ME/CFS. While it's not yet clear if long COVID and ME/CFS are the same, they share enough similarities that mean ME/CFS case numbers could rise significantly in the coming years."
Article l
Thread
..............
Fundraising
Mike Harley posted an update about his next two marathons (Serbia and Albania) to raise funds for Invest in ME. Quote: "I'm only £906 short of £50K fundraising in what is coming up to my 10th year running for ME research."
Just Giving |
Thread
..............
Research news and commentary
Science Solving the puzzle of Long Covid - Ziad Al-Aly and Eric Topol
A good summary of current knowledge on Long Covid. The authors argue that the pandemic has revealed that long-term health loss due to infections has been a blind spot in epidemiology and surveillance data. "Governments and funding agencies should support a comprehensive portfolio of research in infection-associated chronic illnesses. Although SARS-CoV-2 can cause chronic disease, it is not alone. Influenza virus, Epstein-Barr virus, Ebola virus, polio virus, and many others also have long-term health effects. Myalgic encephalomyelitis/ chronic fatigue syndrome is also likely triggered by infection. However, how infectious agents cause chronic disease is not fully understood, and research in this area has been disproportionately underfunded relative to the burden of long-term disability and disease caused by infections."
Article l
Thread
Australia Emerge AusME Biobank
Request for blood donations from patients and healthy volunteers living in New South Wales or Victoria.
AusME Biobank |
Thread
Australia NCNED Low Dose Naltrexone Clinical Trial in Long Covid
NCNED announces they will be starting this trial very shortly.
Facebook Post |
Thread
................
Coming events
USA - NIH ME/CFS Advocacy Call
Monday, March 4, 11 AM to Noon Eastern Time
This webinar will include updates on the NIH ME/CFS Research Roadmap by Vicky Whittemore, Ph.D., Maureen Hanson, Ph.D., and Lucinda (Cindy) Bateman, M.D. During the webinar attendees will have the opportunity to ask questions out loud or to submit written questions in the Zoom Q&A box. Please register in advance.
Announcement |
Registration |
Thread
#MEAction - Partner Caregiver Support Call
Sunday, March 3, 3:00 - 4:00 PM Eastern time
Zoom call for caregivers of people with chronic diseases such as ME or Long COVID. See thread for time in your time zone.
Announcement |
Thread
.................
Research
ME/CFS research
Nature Communications
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome - Walitt, Nath et al.
The long awaited publication of the NIH intramural study of post infectious ME/CFS had 17 participants with ME/CFS and 25 controls. Findings include autonomic and immune dysfunction and brain abnormalities. Response is mixed including concerns about conclusions being drawn from tiny subsamples of patients, and use of the term 'effort preference'. Media coverage is generally positive.
Article |
Thread
Press Statement
“We think that the immune activation is affecting the brain in various ways, causing biochemical changes and downstream effects like motor, autonomic, and cardiorespiratory dysfunction,” said Avindra Nath, M.D., clinical director at NINDS and senior author of the study.
Media:
Stat |
New York Times |
Science Media Centre
Scientific American |
Independent |
Science |
Guardian
Live Science |
NPR |
MedPage Today |
Pulse
Journal of Psychosomatic Research
Psychological risk factors of somatic symptom disorder: A systematic review and meta-analysis of cross-sectional and longitudinal studies - Smakowski et al.
This review found that patients with somatic symptom disorder were more impaired by depression and anxiety compared to healthy controls.
Article |
Thread
Long Covid research
Journal of Infection and Public Health
Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response — Garrido et al.
“The study uncovered substantial changes in various lipid subclasses, presenting a detailed profile of the polar lipid fraction in PCC patients.” “Classification models, such as multinomial regression (MR) and random forest (RF), successfully differentiated between symptomatic and asymptomatic PCC groups using lipidomic profiles.”
Article |
Thread
Nature Neuroscience
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19 — Radke et al.
“Our results indicate that even without persistence of severe acute respiratory syndrome coronavirus 2 in the central nervous system, local immune reactions are prevailing, potentially causing functional disturbances that contribute to neurological complications of COVID-19.”
Article |
Thread
Nature Neuroscience
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment — Greene et al.
“While standard diagnostic MRI scans showed no clinically relevant pathological findings in any participant, DCE-MRI imaging revealed significantly increased whole-brain leakage in patients with long COVID with brain fog”
Article |
Thread
SLEEP Advances
Impact of sleep disruption on cognitive function in patients with postacute sequelae of SARS-CoV-2 infection: initial findings from a Neuro-COVID-19 clinic — Reid et al.
“Actigraphy showed Neuro-PASC patients had lower sleep efficiency, longer sleep latency (both p < 0.001), and later sleep midpoint (p = 0.039) compared to 71 age-matched healthy controls with no PASC history.”
Article |
Thread
European Journal of Neurology
Cognitive domains affected post-COVID-19; a systematic review and meta-analysis — Jack B. Fanshawe et al.
“This review found moderate impairments across multiple domains of cognition in patients post-COVID-19, with no specific pattern.” “The finding of consistent impairment across a range of cognitive tasks suggests broad, as opposed to domain-specific, brain dysfunction.”
Article |
Thread
Nature
Prevalence of persistent SARS-CoV-2 in a large community surveillance study — Ghafari et al.
“Here, using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days.”
Article |
Thread
Journal of Translational Medicine
Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study — Cornelissen et al.
“This study shows persistent fatigue and diverse symptomatology in post COVID-19 patients, up to 12–18 months after SARS-CoV-2 infection. Clustering showed that post COVID-19 patients occurred in 11 of the clusters that have been observed in the ME/CFS cohort.”
Article |
Thread
Science Advances
Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid — Benjamin A. Krishna et al.
“In this study, we reveal that CD8 + T cells from patients diagnosed with Long Covid secrete increased levels of IFN-γ, spontaneously without peptide stimulation, compared to healthy controls. This high IFN-γ secretion correlated with symptom persistence in patients with Long Covid.”
Article |
Thread
Nature Communications Medicine
Carotid body dysregulation contributes to Long COVID symptoms — El-Medany et al.
“The carotid chemoreflex is sensitised in long COVID and may explain dysregulated breathing and exercise intolerance in these participants.”
Article |
Thread
Frontiers in Neurology
Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19 — Havdal et al.
“Serum levels of Nfl and GFAp were almost equal across groups and did not differ from reference values in healthy populations.“
Article |
Thread
..............
S4ME social media:
Forum,
Facebook,
Twitter,
Mastodon and
YouTube